Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
DOI: https://doi.org/10.1016/S1470-2045(23)00405-9
Publication date: September 2023
Connected Trials:
EMN12